Growth characteristics and pathogenesis of experimental Pneumocystis carinii pneumonia.

Infection and Immunity
P D WalzerJ E Milder

Abstract

Pneumocystis carinii pneumonia was produced in two groups of rats by the administration of corticosteroids, a low-protein (8%) diet, and tetracycline in the drinking water. A third group not on corticosteroids or a low-protein diet served as controls. Members of the first group were sacrificed weekly for 8 weeks, and lungs were examined. A highly significant correlation was found between the histopathological assessment of the intensity of P. carinii infection and the number of cysts counted in enzyme-digested lungs. P. carinii progressively filled alveoli, and cyst counts increased from less than or equal to 10(4) to 10(9) cysts/g of lung at peak intensity of infection at 7 to 8 weeks. The second group of rats was placed on a regular diet and tapering doses of corticosteroids after week 4, and they were sacrificed at varying intervals for up to 21 weeks. P. carinii was not cleared from the lungs until after week 13 (more than 6 weeks after discontinuation of all steroids). Histologically, there was an increased prominence of alveolar macrophages and the progressive development of interstitial mononuclear cell infiltrate and fibrosis. Thus, P. carinii grows grows slowly in vivo and interacts with specific host cells. The result...Continue Reading

References

Jan 1, 1977·American Journal of Clinical Pathology·W R WeberL P Dehner
Jun 1, 1979·Experimental Parasitology·P D WalzerB J Stahr
Apr 1, 1977·Pediatric Research·L L PiferM J Murphy
Apr 20, 1978·Zeitschrift Für Parasitenkunde·M E VossenA M Stadhouders
Apr 1, 1978·Infection and Immunity·L L PiferW T Hughes
Jan 1, 1978·The Journal of Experimental Medicine·H Masur, T C Jones
May 1, 1977·Applied and Environmental Microbiology·C R LatorreL G Norman
Dec 1, 1976·Infection and Immunity·M HuppertK R Vukovich
Mar 1, 1975·The Journal of Infectious Diseases·K A WesternA G Kaufmann
Oct 1, 1972·Proceedings of the Society for Experimental Biology and Medicine·H K KimS Feldman
Nov 1, 1970·Annals of Internal Medicine·M E WhitcombP H Larson
Sep 1, 1971·Proceedings of the Society for Experimental Biology and Medicine·J O Hendley, T H Weller
Aug 1, 1970·The Journal of protozoology·J Vavra, K Kucera
Feb 1, 1971·Proceedings of the Society for Experimental Biology and Medicine·S K LimW C Eveland
Jul 1, 1959·The Journal of Experimental Medicine·W H SHELDON

❮ Previous
Next ❯

Citations

Aug 1, 1991·American Journal of Respiratory Cell and Molecular Biology·J M BeckJ E Shellito
Sep 1, 1994·The Korean Journal of Parasitology·S T HongM Lee
Mar 21, 1998·The Journal of Eukaryotic Microbiology·I AccoceberryA Datry
Jan 1, 1989·The Journal of protozoology·M H IveyD C Graves
Aug 1, 1985·Thorax·J T Macfarlane, R G Finch
Mar 5, 1999·Scandinavian Journal of Infectious Diseases·A L Laursen, P L Andersen
Jul 2, 1998·Journal of Endocrinological Investigation·R C BakkerW M Wiersinga
Oct 11, 2001·Microbiology and Immunology·E AngeliciR Canipari
Mar 21, 2017·Journal of Parasitic Diseases : Official Organ of the Indian Society for Parasitology·Mohamad Mohsen HomayouniSaeed Mehravar
Jul 23, 1998·Australian Veterinary Journal·M J FlaminioW E Moore
Aug 1, 1994·Immunology and Cell Biology·C CheersS Houssami
Sep 1, 1996·The Journal of Eukaryotic Microbiology·A M SimonpoliP M Girard
Jan 1, 1992·Critical Reviews in Microbiology·A G Smulian, P D Walzer
Feb 1, 1997·Antimicrobial Agents and Chemotherapy·P D WalzerC L Sidman
May 1, 1988·Journal of Clinical Microbiology·P BrasseurJ J Ballet
Dec 1, 1985·Antimicrobial Agents and Chemotherapy·M T CushionP D Walzer
Dec 1, 1993·Infection and Immunity·W ChenA G Harmsen
Jan 1, 1988·Antimicrobial Agents and Chemotherapy·P D WalzerM T Cushion
May 1, 1991·Journal of Clinical Microbiology·S E LapinskyS Zwi
Aug 1, 1980·Infection and Immunity·K Yoneda, P D Walzer
Jan 1, 1989·Infection and Immunity·P D WalzerL D Shultz
May 1, 1989·Infection and Immunity·M J LinkeP D Walzer
May 1, 1984·Infection and Immunity·M T Cushion, P D Walzer
Jan 1, 1986·Infection and Immunity·D C GravesM A Worley
Jan 1, 1992·Infection and Immunity·H A HidalgoJ A Mangos
Jan 1, 1986·Journal of Clinical Microbiology·J J RuffoloP D Walzer
Jan 1, 1991·Antimicrobial Agents and Chemotherapy·P D WalzerJ L Zhang
Dec 5, 2003·Lancet·Michail S Lionakis, Dimitrios P Kontoyiannis

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.